The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The Pathology of Neoatherosclerosis in Human Coronary Implants
Open accessAbstract
Objectives Human coronary bare metal stents (BMS) and drug-eluting stents (DES) from autopsy cases with implant durations >30 days were examined for the presence of neointimal atherosclerotic disease. Background Neointimal atherosclerotic change (neoatherosclerosis) following BMS implantation is rarely reported and usually occurs beyond 5 years. The incidence of neoatherosclerosis following DES implantation has not been reported. Methods All available cases from the CVPath stent registry (n=299 autopsies), which includes a total of 406 lesions (197 BMS, 209 DES [103 sirolimus-eluting stents (SES), and 106 paclitaxel-eluting stents (PES)]) with implant duration >30 days were examined. Neoatherosclerosis was recognized as clusters of lipid-laden foamy macrophages within the neointima with or without necrotic core formation. Results The incidence of neoatherosclerosis was significantly greater in DES (31%) than BMS (16%) lesions (p<0.001). The median stent duration with neoatherosclerosis was shorter in DES than BMS (DES; 420 [361–683], BMS; 2160 [1800–2880] days, p<0.001). Unstable lesions characterized as thin-cap fibroatheromas or plaque rupture were more frequent in BMS (n=7, 4%) than DES (n=3, 1%) (p=0.17), with relatively shorter implant durations for DES (1.5±0.4 years) compared to BMS (6.1±1.5 years). Independent determinants of neoatherosclerosis identified by multiple logistic regression included younger age (p<0.001), longer implant durations (p<0.001), SES usage (p<0.001), PES usage (p=0.001), and underlying unstable plaques (p=0.004). Conclusions Neoatherosclerosis is a frequent finding in DES and occurs earlier than in BMS. Unstable features of neoatherosclerosis are identified for both BMS and DES with shorter implant durations for the latter. The development of neoatherosclerosis may be yet another rare contributing factor to late thrombotic events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Serruys, P. W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V., Materne, P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310801 · Cited by 4,556
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084
Self-citationMorice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Daemen, J., Wenaweser, P., Tsuchida, K., Abrecht, L., Vaina, S., Morger, C., Kukreja, N., Jüni, P., Sianos, G., Hellige, G., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60314-6 · Cited by 1,757
Virmani, R., Guagliumi, G., Farb, A., Musumeci, G., Grieco, N., Motta, T., Mihalcsik, L., Tespili, M., Valsecchi, O., & Kolodgie, F. D. (2004) · Circulation · doi:10.1161/01.cir.0000116202.41966.d4 · Cited by 1,469
Self-citationOutcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
Stettler, C., Wandel, S., Allemann, S., Kastrati, A., Morice, M. C., Schömig, A., Pfisterer, M. E., Stone, G. W., Leon, M. B., de Lezo, J. S., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61444-5 · Cited by 1,428
Finn, A. V., Joner, M., Nakazawa, G., Kolodgie, F., Newell, J., John, M. C., Gold, H. K., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.107.693739 · Cited by 1,277
Self-citationHemodynamic shear stress and the endothelium in cardiovascular pathophysiology
Davies, P. F. (2009) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1397 · Cited by 1,209
Cited by
Drug-Eluting Coronary-Artery Stents
Stefanini, G. G., & Holmes, D. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1210816 · Cited by 728
Byrne, R. A., Joner, M., & Kastrati, A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv511 · Cited by 609
Current Treatment of In-Stent Restenosis
Alfonso, F., Byrne, R. A., Rivero, F., & Kastrati, A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.545 · Cited by 577
Serruys, P. W., Chevalier, B., Dudek, D., Cequier, A., Carrié, D., Iniguez, A., Dominici, M., van der Schaaf, R. J., Haude, M., Wasungu, L., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61455-0 · Cited by 564
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis
Yahagi, K., Kolodgie, F. D., Otsuka, F., Finn, A. V., Davis, H. R., Joner, M., & Virmani, R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.164 · Cited by 548
Self-citationOtsuka, F., Vorpahl, M., Nakano, M., Foerst, J., Newell, J. B., Sakakura, K., Kutys, R., Ladich, E., Finn, A. V., Kolodgie, F. D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.001790 · Cited by 491
Self-citationOtsuka, F., Byrne, R. A., Yahagi, K., Mori, H., Ladich, E., Fowler, D. R., Kutys, R., Xhepa, E., Kastrati, A., Virmani, R., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv205 · Cited by 491
Self-citationBioresorbable Scaffolds versus Metallic Stents in Routine PCI
Wykrzykowska, J. J., Kraak, R. P., Hofma, S. H., van der Schaaf, R. J., Arkenbout, E. K., IJsselmuiden, A. J., Elias, J., van Dongen, I. M., Tijssen, R. Y. G., Koch, K. T., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614954 · Cited by 441
Optical coherence tomography in coronary atherosclerosis assessment and intervention
Araki, M., Park, S.-J., Dauerman, H. L., Uemura, S., Kim, J.-S., Di Mario, C., Johnson, T. W., Guagliumi, G., Kastrati, A., Joner, M., et al. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00687-9 · Cited by 430
Self-citationPerspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423
The importance of the endothelium in atherothrombosis and coronary stenting
Otsuka, F., Finn, A. V., Yazdani, S. K., Nakano, M., Kolodgie, F. D., & Virmani, R. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.64 · Cited by 402
Self-citationBuccheri, D., Piraino, D., Andolina, G., & Cortese, B. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.10.93 · Cited by 397
Tada, T., Byrne, R. A., Simunovic, I., King, L. A., Cassese, S., Joner, M., Fusaro, M., Schneider, S., Schulz, S., Ibrahim, T., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.06.015 · Cited by 342
Biological responses in stented arteries
Chaabane, C., Otsuka, F., Virmani, R., & Bochaton-Piallat, M.-L. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt115 · Cited by 335
Self-citationSerruys, P. W., Farooq, V., Kalesan, B., de Vries, T., Buszman, P., Linke, A., Ischinger, T., Klauss, V., Eberli, F., Wijns, W., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.04.011 · Cited by 331
Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography
Taniwaki, M., Radu, M. D., Zaugg, S., Amabile, N., Garcia-Garcia, H. M., Yamaji, K., Jørgensen, E., Kelbæk, H., Pilgrim, T., Caussin, C., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019071 · Cited by 327
Alfonso, F., Pérez-Vizcayno, M. J., Cárdenas, A., García del Blanco, B., García-Touchard, A., López-Minguéz, J. R., Benedicto, A., Masotti, M., Zueco, J., Iñiguez, A., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.063 · Cited by 313
Serruys, P. W., Garcia-Garcia, H. M., & Onuma, Y. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr384 · Cited by 303
Kandzari, D. E., Mauri, L., Koolen, J. J., Massaro, J. M., Doros, G., Garcia-Garcia, H. M., Bennett, J., Roguin, A., Gharib, E. G., Cutlip, D. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32249-3 · Cited by 279
Bioresorbable scaffolds: rationale, current status, challenges, and future
Iqbal, J., Onuma, Y., Ormiston, J., Abizaid, A., Waksman, R., & Serruys, P. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht542 · Cited by 269
Current Status of Bioresorbable Scaffolds in the Treatment of Coronary Artery Disease
Wiebe, J., Nef, H. M., & Hamm, C. W. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.041 · Cited by 255
New concepts in the design of drug-eluting coronary stents
Garg, S., Bourantas, C., & Serruys, P. W. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.13 · Cited by 125
Pei, C., Zhang, Y., Wang, P., Zhang, B., Fang, L., Liu, B., & Meng, S. (2019) · Phytotherapy Research · doi:10.1002/ptr.6217 · Cited by 80
Ito, T., Fujita, H., Tani, T., & Ohte, N. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.026 · Cited by 30
“BetweenMarch 2009 and April 2013, a total of 524 patients with stable angina were treated with PCI using DES in our institute.”
BackgroundInfluentialBioresorbable Stents: Is This Where We Are Headed?
Wayangankar, S. A., & Ellis, S. G. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.08.011 · Cited by 18
Metadata
- Authors
- Nakazawa, G., Otsuka, F., Nakano, M., Vorpahl, M., Yazdani, S. K., Ladich, E., Kolodgie, F. D., Finn, A. V., & Virmani, R.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 57
- Issue
- 11
- Pages
- 1314-1322
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W146325010
- Cited by
- 934
- References
- 18
- FWCI
- 87.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.